Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Grant-Klein RJ"'
Autor:
Simon JK; Merck & Co., Inc., Rahway, NJ, USA., Kennedy SB; Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), Monrovia, Liberia., Mahon BE; Centers for Disease Control and Prevention, Atlanta, GA, USA., Dubey SA; Merck & Co., Inc., Rahway, NJ, USA., Grant-Klein RJ; Merck & Co., Inc., Rahway, NJ, USA., Liu K; Merck & Co., Inc., Rahway, NJ, USA., Hartzel J; Merck & Co., Inc., Rahway, NJ, USA., Coller BG; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: beth-ann.coller@merck.com., Welebob C; Merck & Co., Inc., Rahway, NJ, USA., Hanson ME; Merck & Co., Inc., Rahway, NJ, USA., Grais RF; Epicentre, Paris, France.
Publikováno v:
Vaccine [Vaccine] 2022 Nov 02; Vol. 40 (46), pp. 6599-6606. Date of Electronic Publication: 2022 Oct 05.
Autor:
Rajam G; Merck & Co., Inc., Rahway, New Jersey, USA., Zhang Y; Merck & Co., Inc., Rahway, New Jersey, USA., Antonello JM; Merck & Co., Inc., Rahway, New Jersey, USA., Grant-Klein RJ; Merck & Co., Inc., Rahway, New Jersey, USA., Cook L; Merck & Co., Inc., Rahway, New Jersey, USA., Panemangalore R; Merck & Co., Inc., Rahway, New Jersey, USA., Pham H; Merck & Co., Inc., Rahway, New Jersey, USA., Cooper S; Merck & Co., Inc., Rahway, New Jersey, USA., Steinmetz TD; Merck & Co., Inc., Rahway, New Jersey, USA., Nguyen J; Merck & Co., Inc., Rahway, New Jersey, USA., Pletz MW; Institute for Infectious Diseases and Infection Control, Jena University Hospitalgrid.275559.9, Jena, Thuringia, Germany.; CAPNETZ Stiftung, Hannover, Germany., Barten-Neiner G; CAPNETZ Stiftung, Hannover, Germany.; Biomedical Research in Endstage and Obstructive Lung Disease Hannover, Hannover, Germany., Murphy RD; Merck & Co., Inc., Rahway, New Jersey, USA., Rubinstein LJ; Merck & Co., Inc., Rahway, New Jersey, USA., Nolan KM; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
MSphere [mSphere] 2022 Aug 31; Vol. 7 (4), pp. e0011422. Date of Electronic Publication: 2022 Aug 01.
Autor:
Grant-Klein RJ; 1Merck & Co., Inc., Kenilworth, New Jersey., Antonello J; 1Merck & Co., Inc., Kenilworth, New Jersey., Nichols R; 2Crozet BioPharma, Devens, Massachusetts., Dubey S; 1Merck & Co., Inc., Kenilworth, New Jersey., Simon JK; 1Merck & Co., Inc., Kenilworth, New Jersey.
Publikováno v:
The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2021 Mar 29; Vol. 104 (5), pp. 1751-1754. Date of Electronic Publication: 2021 Mar 29.
Autor:
Grais RF; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org., Kennedy SB; Partnership for Research on Ebola Virus in Liberia, Monrovia, Liberia., Mahon BE; Centers for Disease Control and Prevention, Atlanta, GA, USA., Dubey SA; Merck & Co, Kenilworth, NJ, USA., Grant-Klein RJ; Merck & Co, Kenilworth, NJ, USA., Liu K; Merck & Co, Kenilworth, NJ, USA., Hartzel J; Merck & Co, Kenilworth, NJ, USA., Coller BA; Merck & Co, Kenilworth, NJ, USA., Welebob C; Merck & Co, Kenilworth, NJ, USA., Hanson ME; Merck & Co, Kenilworth, NJ, USA., Simon JK; Merck & Co, Kenilworth, NJ, USA.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2021 Feb; Vol. 2 (2), pp. e70-e78. Date of Electronic Publication: 2021 Feb 02.
Autor:
Antonello J; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: joseph_antonello@merck.com., Grant-Klein RJ; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: rebecca.klein1@merck.com., Nichols R; Crozet BioPharma LLC., Devens, MA, USA. Electronic address: rick.nichols@crozetbiopharma.com., Kennedy SB; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia. Electronic address: sbkennedy4@aol.com., Dubey S; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: sheri_dubey@merck.com., Simon JK; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: jakub.simon@merck.com.
Publikováno v:
Vaccine [Vaccine] 2020 Jun 26; Vol. 38 (31), pp. 4885-4891. Date of Electronic Publication: 2020 Jun 01.
Autor:
Halperin SA; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, Canada., Das R; Merck & Co., Inc., Kenilworth, New Jersey., Onorato MT; Merck & Co., Inc., Kenilworth, New Jersey., Liu K; Merck & Co., Inc., Kenilworth, New Jersey., Martin J; Merck & Co., Inc., Kenilworth, New Jersey., Grant-Klein RJ; Merck & Co., Inc., Kenilworth, New Jersey., Nichols R; NewLink Genetics, Inc., BioProtection Systems, Ames, Iowa., Coller BA; Merck & Co., Inc., Kenilworth, New Jersey., Helmond FA; Merck & Co., Inc., Kenilworth, New Jersey., Simon JK; Merck & Co., Inc., Kenilworth, New Jersey.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Aug 30; Vol. 220 (7), pp. 1127-1135.
Autor:
Grant-Klein RJ; Merck & Co., Inc., Kenilworth, New Jersey., Antonello J; Merck & Co., Inc., Kenilworth, New Jersey., Nichols R; Crozet BioPharma, Devens, Massachusetts., Dubey S; Merck & Co., Inc., Kenilworth, New Jersey., Simon J; Merck & Co., Inc., Kenilworth, New Jersey.
Publikováno v:
The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2019 Jul; Vol. 101 (1), pp. 207-213.
Autor:
Coller BG; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: beth-ann.coller@merck.com., Blue J; Merck & Co., Inc., Kenilworth, NJ, USA., Das R; Merck & Co., Inc., Kenilworth, NJ, USA., Dubey S; Merck & Co., Inc., Kenilworth, NJ, USA., Finelli L; Merck & Co., Inc., Kenilworth, NJ, USA., Gupta S; Merck & Co., Inc., Kenilworth, NJ, USA., Helmond F; Merck & Co., Inc., Kenilworth, NJ, USA., Grant-Klein RJ; Merck & Co., Inc., Kenilworth, NJ, USA., Liu K; Merck & Co., Inc., Kenilworth, NJ, USA., Simon J; Merck & Co., Inc., Kenilworth, NJ, USA., Troth S; Merck & Co., Inc., Kenilworth, NJ, USA., VanRheenen S; Merck & Co., Inc., Kenilworth, NJ, USA., Waterbury J; Merck & Co., Inc., Kenilworth, NJ, USA., Wivel A; Merck & Co., Inc., Kenilworth, NJ, USA., Wolf J; Merck & Co., Inc., Kenilworth, NJ, USA., Heppner DG; NewLink Genetics, Inc./BioProtection Systems, Ames, IA, USA., Kemp T; NewLink Genetics, Inc./BioProtection Systems, Ames, IA, USA., Nichols R; NewLink Genetics, Inc./BioProtection Systems, Ames, IA, USA., Monath TP; NewLink Genetics, Inc./BioProtection Systems, Ames, IA, USA.
Publikováno v:
Vaccine [Vaccine] 2017 Aug 16; Vol. 35 (35 Pt A), pp. 4465-4469. Date of Electronic Publication: 2017 Jun 21.
Autor:
Grant-Klein RJ; a United States Army Medical Research Institute of Infectious Diseases ; Fort Detrick , MD USA., Altamura LA, Badger CV, Bounds CE, Van Deusen NM, Kwilas SA, Vu HA, Warfield KL, Hooper JW, Hannaman D, Dupuy LC, Schmaljohn CS
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2015; Vol. 11 (8), pp. 1991-2004.
Autor:
Grant-Klein RJ; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA. Rebecca.J.Klein@us.army.mil, Van Deusen NM, Badger CV, Hannaman D, Dupuy LC, Schmaljohn CS
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2012 Nov 01; Vol. 8 (11), pp. 1703-6. Date of Electronic Publication: 2012 Aug 24.